Effect of preoperative prophylactic intravenous tranexamic acid on perioperative blood loss control in patients undergoing cesarean delivery: a systematic review and meta-analysis
- PMID: 37280562
- PMCID: PMC10245530
- DOI: 10.1186/s12884-023-05753-9
Effect of preoperative prophylactic intravenous tranexamic acid on perioperative blood loss control in patients undergoing cesarean delivery: a systematic review and meta-analysis
Abstract
Background: Postpartum hemorrhage (PPH) is one of the important risk factors leading to maternal mortality and intervention is essential. Oxytocin therapy is widely used clinically, but the effect is unsatisfactory. The efficacy of tranexamic acid (TXA) in hemostasis is notable, whereas its use in preventing PPH warrants exploration.
Aims: To evaluate the effect of prophylactic administration of TXA on perioperative blood loss in women undergoing cesarean section by systematic review and meta-analysis of published studies.
Methods: Bibliographic databases were screened from their inception to December 2022 to retrieve relevant studies. Study outcomes including blood loss during cesarean section, 2-h postpartum blood loss, total blood loss (during cesarean section and 2-h postpartum), and 6-h postpartum, as well as hemoglobin changes were extracted and compared.
Results: A total of 21 studies, nine randomized clinical trials and 12 cohort studies, involving 1896 patients given TXA prophylactically and 1909 patients given placebo or no treatment, were analyzed. Compared with the control group, the preoperative prophylactic intravenous administration of TXA significantly reduced the intraoperative (RCT: P < 0.00001, cohort studies: P < 0.00001), 2-h postpartum (RCT: P = 0.02, cohort studies: P < 0.00001) and total blood loss (RCT: P < 0.00001, cohort studies: P = 0.0002), and reduced the decline in hemoglobin (RCT: P < 0.00001, cohort studies: P = 0.0001), but did not significantly affect blood loss at 6-h postpartum (P = 0.05).
Conclusion: Prophylactic intravenous TXA before cesarean section is helpful in preventing perioperative bleeding in women.
Trial registration: http://www.crd.york.ac.uk/PROSPERO , identifier: CRD 42022363450.
Keywords: Cesarean delivery; Postpartum hemorrhage; Tranexamic acid.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Prophylactic Tranexamic Acid Prevents Postpartum Hemorrhage and Transfusions in Cesarean Deliveries: A Systematic Review and Meta-analysis.Am J Perinatol. 2024 May;41(S 01):e2254-e2268. doi: 10.1055/a-2109-3730. Epub 2023 Jun 13. Am J Perinatol. 2024. PMID: 37311543
-
Effect of Prophylactic Intraoperative Tranexamic Acid on Postpartum Blood Loss Following Cesarean Section at a Single Center.Med Sci Monit. 2025 May 28;31:e947904. doi: 10.12659/MSM.947904. Med Sci Monit. 2025. PMID: 40468921 Free PMC article. Clinical Trial.
-
TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial - a study protocol.BMC Pregnancy Childbirth. 2020 Jan 31;20(1):63. doi: 10.1186/s12884-019-2718-4. BMC Pregnancy Childbirth. 2020. PMID: 32005192 Free PMC article.
-
Meta-analysis: the prophylactic use of tranexamic acid to reduce blood loss during caesarean delivery.Ir J Med Sci. 2025 Feb;194(1):311-322. doi: 10.1007/s11845-024-03834-y. Epub 2024 Dec 9. Ir J Med Sci. 2025. PMID: 39652279 Review.
-
Prophylactic tranexamic acid in Cesarean delivery: an updated meta-analysis with a trial sequential analysis.Can J Anaesth. 2024 Apr;71(4):465-478. doi: 10.1007/s12630-024-02715-3. Epub 2024 Mar 7. Can J Anaesth. 2024. PMID: 38453797 English.
Cited by
-
[Early effectiveness of local injection of multimodal drug cocktail during anterior cruciate ligament reconstruction and its influence on cartilage].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024 May 15;38(5):562-569. doi: 10.7507/1002-1892.202402054. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024. PMID: 38752242 Free PMC article. Clinical Trial. Chinese.
-
Tranexamic acid versus oxytocin prophylaxis in reducing post-partum blood loss, in low-risk pregnant women: TRANOXY STUDY, a phase III randomized clinical trial.EClinicalMedicine. 2024 May 31;73:102665. doi: 10.1016/j.eclinm.2024.102665. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 38873634 Free PMC article.
-
Tranexamic acid for preventing postpartum haemorrhage after vaginal birth.Cochrane Database Syst Rev. 2025 Jan 15;1(1):CD007872. doi: 10.1002/14651858.CD007872.pub4. Cochrane Database Syst Rev. 2025. PMID: 39812173 Free PMC article.
-
Quantitative prediction of postpartum hemorrhage in cesarean section on machine learning.BMC Med Inform Decis Mak. 2024 Jun 13;24(1):166. doi: 10.1186/s12911-024-02571-7. BMC Med Inform Decis Mak. 2024. PMID: 38872184 Free PMC article.
-
Tranexamic acid for preventing postpartum haemorrhage after caesarean section.Cochrane Database Syst Rev. 2024 Nov 13;11(11):CD016278. doi: 10.1002/14651858.CD016278. Cochrane Database Syst Rev. 2024. PMID: 39535297 Free PMC article.
References
-
- the Scottish Committee of the Royal College of Obstetricians and Gynaecologists: Prevention and Management of Postpartum Haemorrhage: Green-top Guideline No. 52. Bjog 2017, 124(5):e106-e149. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources